Innosuisse-Funded Alzheimer’s Clinical Trial with MIAMIND®
Explore an Innosuisse-funded clinical trial evaluating MIAMIND® for Alzheimer’s disease and potential impact on future treatments.
Bottneuro Launches Miamind.ch
Bottneuro AG announces the launch of miamind.com, the official online platform for the Miamind® Neurostimulator.